Literature DB >> 31625145

Biallelic inherited SCN8A variants, a rare cause of SCN8A-related developmental and epileptic encephalopathy.

Eric R Wengert1,2, Cathrine E Tronhjem3, Jacy L Wagnon4,5, Katrine M Johannesen3,6, Hayley Petit4, Ilona Krey7, Anusha U Saga1, Payal S Panchal1, Samantha M Strohm1, Jörn Lange8, Susanne B Kamphausen9, Guido Rubboli3,10, Johannes R Lemke7, Elena Gardella3,6, Manoj K Patel1,2, Miriam H Meisler4, Rikke S Møller3,6.   

Abstract

OBJECTIVE: Monoallelic de novo gain-of-function variants in the voltage-gated sodium channel SCN8A are one of the recurrent causes of severe developmental and epileptic encephalopathy (DEE). In addition, a small number of de novo or inherited monoallelic loss-of-function variants have been found in patients with intellectual disability, autism spectrum disorder, or movement disorders. Inherited monoallelic variants causing either gain or loss-of-function are also associated with less severe conditions such as benign familial infantile seizures and isolated movement disorders. In all three categories, the affected individuals are heterozygous for a SCN8A variant in combination with a wild-type allele. In the present study, we describe two unusual families with severely affected individuals who inherited biallelic variants of SCN8A.
METHODS: We identified two families with biallelic SCN8A variants by diagnostic gene panel sequencing. Functional analysis of the variants was performed using voltage clamp recordings from transfected ND7/23 cells.
RESULTS: We identified three probands from two unrelated families with DEE due to biallelic SCN8A variants. Each parent of an affected individual carried a single heterozygous SCN8A variant and exhibited mild cognitive impairment without seizures. In both families, functional analysis demonstrated segregation of one allele with complete loss-of-function, and one allele with altered biophysical properties consistent with partial loss-of-function. SIGNIFICANCE: These studies demonstrate that SCN8A DEE may, in rare cases, result from inheritance of two variants, both of which exhibit reduced channel activity. In these families, heterozygosity for the dominant variants results in less severe disease than biallelic inheritance of two variant alleles. The clinical consequences of variants with partial and complete loss of SCN8A function are variable and likely to be influenced by genetic background. Wiley Periodicals, Inc.
© 2019 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31625145      PMCID: PMC6842408          DOI: 10.1111/epi.16371

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  31 in total

1.  The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009.

Authors:  Allan Bayat; Helle Hjalgrim; Rikke S Møller
Journal:  Epilepsia       Date:  2015-03-16       Impact factor: 5.864

2.  Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Na(v)1.6).

Authors:  Jennifer A Kearney; David A Buchner; Georgius De Haan; Maja Adamska; Stephen I Levin; Amy R Furay; Roger L Albin; Julie M Jones; Mauricio Montal; Martin J Stevens; Leslie K Sprunger; Miriam H Meisler
Journal:  Hum Mol Genet       Date:  2002-10-15       Impact factor: 6.150

3.  Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.

Authors:  Markus Wolff; Katrine M Johannesen; Ulrike B S Hedrich; Silvia Masnada; Guido Rubboli; Elena Gardella; Gaetan Lesca; Dorothée Ville; Mathieu Milh; Laurent Villard; Alexandra Afenjar; Sandra Chantot-Bastaraud; Cyril Mignot; Caroline Lardennois; Caroline Nava; Niklas Schwarz; Marion Gérard; Laurence Perrin; Diane Doummar; Stéphane Auvin; Maria J Miranda; Maja Hempel; Eva Brilstra; Nine Knoers; Nienke Verbeek; Marjan van Kempen; Kees P Braun; Grazia Mancini; Saskia Biskup; Konstanze Hörtnagel; Miriam Döcker; Thomas Bast; Tobias Loddenkemper; Lily Wong-Kisiel; Friedrich M Baumeister; Walid Fazeli; Pasquale Striano; Robertino Dilena; Elena Fontana; Federico Zara; Gerhard Kurlemann; Joerg Klepper; Jess G Thoene; Daniel H Arndt; Nicolas Deconinck; Thomas Schmitt-Mechelke; Oliver Maier; Hiltrud Muhle; Beverly Wical; Claudio Finetti; Reinhard Brückner; Joachim Pietz; Günther Golla; Dinesh Jillella; Karen M Linnet; Perrine Charles; Ute Moog; Eve Õiglane-Shlik; John F Mantovani; Kristen Park; Marie Deprez; Damien Lederer; Sandrine Mary; Emmanuel Scalais; Laila Selim; Rudy Van Coster; Lieven Lagae; Marina Nikanorova; Helle Hjalgrim; G Christoph Korenke; Marina Trivisano; Nicola Specchio; Berten Ceulemans; Thomas Dorn; Katherine L Helbig; Katia Hardies; Hannah Stamberger; Peter de Jonghe; Sarah Weckhuysen; Johannes R Lemke; Ingeborg Krägeloh-Mann; Ingo Helbig; Gerhard Kluger; Holger Lerche; Rikke S Møller
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

4.  A Novel Inherited Mutation of SCN8A in a Korean Family with Benign Familial Infantile Epilepsy Using Diagnostic Exome Sequencing.

Authors:  Ji Yoon Han; Ja Hyun Jang; In Goo Lee; Soyoung Shin; Joonhong Park
Journal:  Ann Clin Lab Sci       Date:  2017-11       Impact factor: 1.256

5.  Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation.

Authors:  M M Trudeau; J C Dalton; J W Day; L P W Ranum; M H Meisler
Journal:  J Med Genet       Date:  2005-10-19       Impact factor: 6.318

6.  Prominent role of forebrain excitatory neurons in SCN8A encephalopathy.

Authors:  Rosie K A Bunton-Stasyshyn; Jacy L Wagnon; Eric R Wengert; Bryan S Barker; Alexa Faulkner; Pravin K Wagley; Kritika Bhatia; Julie M Jones; Marissa R Maniaci; Jack M Parent; Howard P Goodkin; Manoj K Patel; Miriam H Meisler
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

7.  Pathogenic mechanism of recurrent mutations of SCN8A in epileptic encephalopathy.

Authors:  Jacy L Wagnon; Bryan S Barker; James A Hounshell; Charlotte A Haaxma; Amy Shealy; Timothy Moss; Sumit Parikh; Ricka D Messer; Manoj K Patel; Miriam H Meisler
Journal:  Ann Clin Transl Neurol       Date:  2015-12-21       Impact factor: 4.511

8.  Voltage-gated sodium channels assemble and gate as dimers.

Authors:  Jérôme Clatot; Malcolm Hoshi; Xiaoping Wan; Haiyan Liu; Ankur Jain; Krekwit Shinlapawittayatorn; Céline Marionneau; Eckhard Ficker; Taekjip Ha; Isabelle Deschênes
Journal:  Nat Commun       Date:  2017-12-12       Impact factor: 14.919

9.  Loss-of-function variants of SCN8A in intellectual disability without seizures.

Authors:  Jacy L Wagnon; Bryan S Barker; Matteo Ottolini; Young Park; Alicia Volkheimer; Purnima Valdez; Marielle E M Swinkels; Manoj K Patel; Miriam H Meisler
Journal:  Neurol Genet       Date:  2017-06-07

10.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

View more
  4 in total

Review 1.  The physiological function of different voltage-gated sodium channels in pain.

Authors:  George Goodwin; Stephen B McMahon
Journal:  Nat Rev Neurosci       Date:  2021-03-29       Impact factor: 34.870

2.  NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats.

Authors:  J P Johnson; Thilo Focken; Kuldip Khakh; Parisa Karimi Tari; Celine Dube; Samuel J Goodchild; Jean-Christophe Andrez; Girish Bankar; David Bogucki; Kristen Burford; Elaine Chang; Sultan Chowdhury; Richard Dean; Gina de Boer; Shannon Decker; Christoph Dehnhardt; Mandy Feng; Wei Gong; Michael Grimwood; Abid Hasan; Angela Hussainkhel; Qi Jia; Stephanie Lee; Jenny Li; Sophia Lin; Andrea Lindgren; Verner Lofstrand; Janette Mezeyova; Rostam Namdari; Karen Nelkenbrecher; Noah Gregory Shuart; Luis Sojo; Shaoyi Sun; Matthew Taron; Matthew Waldbrook; Diana Weeratunge; Steven Wesolowski; Aaron Williams; Michael Wilson; Zhiwei Xie; Rhena Yoo; Clint Young; Alla Zenova; Wei Zhang; Alison J Cutts; Robin P Sherrington; Simon N Pimstone; Raymond Winquist; Charles J Cohen; James R Empfield
Journal:  Elife       Date:  2022-03-02       Impact factor: 8.140

Review 3.  Sodium channelopathies in neurodevelopmental disorders.

Authors:  Miriam H Meisler; Sophie F Hill; Wenxi Yu
Journal:  Nat Rev Neurosci       Date:  2021-02-02       Impact factor: 34.870

4.  Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome.

Authors:  Guy M Lenk; Paymaan Jafar-Nejad; Sophie F Hill; Lucas D Huffman; Corrine E Smolen; Jacy L Wagnon; Hayley Petit; Wenxi Yu; Julie Ziobro; Kritika Bhatia; Jack Parent; Roman J Giger; Frank Rigo; Miriam H Meisler
Journal:  Ann Neurol       Date:  2020-02-06       Impact factor: 10.422

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.